Core Insights - LimX Dynamics officially launched the embodied intelligent system LimX COSA (Cognitive OS of Agents) on January 12 [1] - LimX COSA is designed as an Agentic OS native to the physical world, integrating high-level cognition with full-body motion control [1] - The full-sized humanoid robot Oli is the first to utilize the COSA system, achieving a combination of motion intelligence and high-level cognitive capabilities [1] Company Overview - LimX Dynamics focuses on developing advanced intelligent systems that enhance the interaction between machines and the physical world [1] - The introduction of LimX COSA marks a significant advancement in the field of robotics, particularly in creating intelligent agents capable of thinking and acting simultaneously [1] Industry Implications - The launch of LimX COSA could set a new standard in the robotics industry, emphasizing the importance of cognitive capabilities in humanoid robots [1] - The integration of high-level cognition with physical movement may lead to new applications and innovations in various sectors, including manufacturing, healthcare, and service industries [1]

北京商报讯(记者魏蔚)1月12日，自变量机器人已于近期完成10亿元A++轮融资。本轮融资由字节跳 动、红杉中国、北京信息产业发展基金、深创投、南山战新投、锡创投等投资机构及多元地方平台联合 投资。2023年12月，自变量机器人完成天使轮融资，并成立运营实体，2024年4月迭代出初版具身智能 底座大模型。自变量机器人创始人兼CEO王潜表示："具身智能的下一阶段竞争，本质上还是数据闭环 构建的基础模型与模型进化能力的竞争"。全球正在从数据、模型、算力等多个方面加快投入，快速推 进具身智能的发展。 ...

Core Insights - Zhiyun and Didi have announced a strategic partnership to explore key technologies in General Artificial Intelligence (AGI) and their applications in the transportation sector [1] - The collaboration aims to enhance intention alignment and reasoning capabilities in travel scenarios, facilitating the validation and implementation of agents in more complex business environments [1] Company Collaboration - The partnership focuses on forward-looking collaborative exploration between Zhiyun and Didi [1] - Both companies will work together to deepen the integration of AGI technologies in the mobility sector [1] Technology Development - The initiative will promote the development of intelligent agents in various business contexts [1] - Emphasis will be placed on improving the reasoning capabilities and intention alignment within travel applications [1]

安全生产责任保险(以下简称"安责险")背后的事故预防服务投入不足问题被一地揪出。1月11日，北京 商报记者了解到，近日广西壮族自治区安委会办公室召开集体约谈会。此次集体约谈直指部分保险公司 安责险实施中的两大核心问题："预防费用占比低"和"人均保额不达标"。 有关部门提出了具体整改措施和完成时限。要求相关保险公司制定2026年度安责险事故预防服务费用预 算时，严格按照不低于保费总额的20%计提和投入。在业内人士看来，这一明确比例的规定，旨在从根 本上改变过去预防投入不足的状况。同时，部分保险公司在开展安责险业务时的重保费、轻预防问题亟 待解决。 预防费用投入迎硬性比例 近日，广西壮族自治区安委会办公室召开集体约谈会，对9家安责险重点保险公司进行集体约谈。会 上，通报了当前该区安责险事故预防工作情况，重点就"预防费用占比低"和"人均保额不达标"等问题的 原因进行了深入剖析，并提出了具体整改措施和完成时限。会议要求，各保险公司要深刻反思问题根 源，做到立行立改；要建立健全责任体系，确保整改到位。 会议强调，各保险公司要立下书面承诺，明确投入底线，在制定2026年度安责险事故预防服务费用的预 算和目标时，将严格按照 ...

A股贵金属板块集体高开，截至9:45，明牌珠宝涨超6%，盛达资源、晓程科技涨超5%，湖南白银、中 国白银集团均涨超4%，中国黄金国际、灵宝黄金等多股跟涨。 （文章来源：北京商报） 北京商报讯1月12日早盘，伦敦金现最高突破4600美元/盎司关键关口，伦敦银现最高触及84美元/盎 司，均创历史新高。 ...

Group 1 - In 2025, Beijing Automotive Group (BAIC Group) achieved total vehicle sales of 1.752 million units, representing a year-on-year growth of 5.6% [1] - The sales of BAIC's self-owned brands reached 1.07 million units, accounting for 61% of total sales [1] - The Arcfox brand saw sales of 163,000 units, marking a significant year-on-year increase of 101%, with sales doubling for two consecutive years [1] Group 2 - Beijing Off-road vehicles sold over 200,000 units in 2025, reflecting a year-on-year growth of 38%, with the BJ40 model leading the hard-core off-road vehicle sales for 11 consecutive months [1] - The Xiangjie brand achieved monthly sales exceeding 10,000 units, maintaining its position as the top seller in the 300,000 to 500,000 yuan new energy sedan market [1] - BAIC Group exported 308,000 vehicles in 2025, setting a historical record with a year-on-year growth of 26%, outpacing the industry growth rate by 7.3 percentage points [1]

北京商报讯(记者马换换李佳雪)1月12日早间，深交所官网显示，湖南黄金（002155）拟筹划发行股份 购买资产并募集配套资金暨关联交易事项，公司股票于1月12日开市起临时停牌，待公司通过指定媒体 披露相关公告后复牌。 ...

Core Viewpoint - The cancellation of the export VAT rebate for photovoltaic products marks the end of the "rebate subsidy era" for the industry, leading to significant impacts on component manufacturers and a potential surge in exports before the policy takes effect [3][4][6]. Group 1: Policy Changes - The Ministry of Finance and the State Taxation Administration announced the cancellation of the export VAT rebate for photovoltaic products effective April 1, 2024, with a gradual reduction for battery products starting in 2026 [3][4]. - The announcement includes a list of 249 photovoltaic products and 22 battery products affected by the policy change [3]. - The China Photovoltaic Industry Association stated that the adjustment aims to promote rational pricing in foreign markets and curb the rapid decline in export prices [3][4]. Group 2: Industry Impact - The cancellation of the export VAT rebate is expected to significantly affect component manufacturers, leading to a "rush to export" before the policy takes effect [4][6]. - Major manufacturers like JinkoSolar, Trina Solar, JA Solar, and Longi Green Energy reported substantial losses in the first three quarters of 2025, with revenues of approximately 479.86 billion, 499.7 billion, 368.09 billion, and 509.15 billion respectively [5]. - JinkoSolar had the highest share of overseas revenue, exceeding 60%, while Longi Green Energy had the lowest at around 37.81% [5]. Group 3: Market Dynamics - The industry is experiencing fierce competition, with export prices declining and a trend of "increased volume but decreased price" [4][6]. - The cancellation of the rebate is seen as a shift from a "policy-driven" to a "market-driven" approach, pushing companies to focus on value rather than price competition [8][9]. - Companies may need to upgrade technology and reduce production costs to maintain competitiveness, potentially leading to a shift of production capacity to regions with favorable tax conditions [8][9].

武泽伟也持相似观点，他补充道，部分银行可能基于全年处置计划将转让项目后置，加之市场参与方对 新增合规要求尚处适应期，暂时观望情绪上升。但从全年看，他认为，随着银行不良处置压力持续存 在、平台机制不断成熟，市场活跃度有望逐步回升，政策优惠将与资产供给节奏形成动态配合。 开年之际，银行不良贷款转让市场再度迎来利好：银登中心继续对转让业务暂免收取挂牌服务费，并对 交易服务费给予8折优惠。起步于2021年1月的不良贷款转让试点即将进入第六个年头，分析人士指出， 银行不良处置压力持续存在、平台机制不断成熟，市场活跃度有望逐步回升，政策优惠将与资产供给节 奏形成动态配合，在监管趋严与政策扶持并行的新阶段，银行如何借助市场化渠道实现不良贷款精 准"拆弹"，成为行业关注的核心课题。 费率优惠再度延长 新年伊始，银行不良贷款转让市场迎来双重政策利好。1月7日，银登中心发布通知，明确自2026年1月1 日起，继续对不良贷款转让业务暂免收取挂牌服务费，并对交易服务费给予8折优惠；同时，有消息 称，监管部门已将不良贷款转让试点期限延长至2026年12月31日。 根据银登中心2022年出台的不良贷款转让收费办法，挂牌服务费针对出让方收 ...

Core Viewpoint - Wanfu Bio is expected to report its worst performance since its IPO in 2015, with a projected net profit of 46 million to 69 million yuan for 2025, representing a year-on-year decline of 87.71% to 91.81% [1] Group 1: Financial Performance - The company anticipates a non-net profit of -7.5 million to -15 million yuan for 2025, marking its first-ever loss in this category since going public [2] - The decline in main business revenue is attributed to a drop in domestic income, influenced by VAT rate adjustments and policy impacts on hospital business, leading to pressure on both volume and price [2] - Factors contributing to the decline in net profit include price reductions in the domestic market, changes in product structure, a decrease in consolidated gross margin, high R&D and sales expenses, and impairment losses from divesting non-core, low-profitability businesses [2] Group 2: Market Performance - Despite domestic market challenges, Wanfu Bio has seen stable growth in overseas markets, particularly in North America, where a long-term supply agreement for respiratory products has been established [3] - The company's stock price has underperformed, with a cumulative decline of 9.15% in 2025, compared to a 29.87% increase in the overall market, and a drop of over 70% from its peak in 2020 [3][4] Group 3: Strategic Initiatives - To reverse the declining performance and stock price, the company is focusing on product specialization, cost control, channel upgrades, accelerated overseas expansion, governance optimization, and market value management [4] - The company has decided to postpone the implementation of the "Knowledge City Production Base Construction Project" to avoid resource waste and improve the efficiency of fundraising, given the significant changes in the internal and external operating environment [4] Group 4: Future Outlook - For 2026, the company plans to leverage market recovery in the domestic sector, focusing on core product lines to improve revenue, while continuing to expand in overseas markets [5] - The company aims to commercialize AI applications in pathology and clinical diagnostics, and to enhance its business from point-of-care (POC) to in vitro diagnostics (IVD), accelerating its international expansion [5]